RTW Biotech Opportunities Ltd RTWFF
Rating
Rating Factors
Company Overview
RTW Biotech Opportunities Ltd is a closed-ended investment company focused on the biotechnology and life sciences sectors. The company’s core activity is investing in publicly traded and private biotech companies developing novel therapeutics, platform technologies, and life science innovations. It operates within the healthcare investment and biotechnology finance industries, providing capital to companies across various stages of clinical development.
The company’s primary revenue driver is capital appreciation from its investment portfolio, supplemented by gains from private-to-public transitions and selective exits. RTW Biotech Opportunities Ltd primarily serves institutional and sophisticated investors seeking exposure to biotechnology innovation through an actively managed structure. Its strategic advantage lies in being externally managed by RTW Investments, a specialist life sciences investment firm with deep scientific, clinical, and regulatory expertise. The company was incorporated in 2019 and launched following its initial public offering on the London Stock Exchange, positioning itself as a long-term capital provider to the global biotech ecosystem.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
- Low
- $1.56
- Current
- $2.45
- High
- $2.68
Valuation
Dividends and Shares
Corporate Info
Seventh Floor
New York, NY 10014